Gynecologic Cancer
Commentary
Discontinuing immunotherapy: Is the infusion bag half empty or half full?
Clinical trials of immunotherapy or chemoimmunotherapy have generally terminated treatment in nonprogressing patients after 2 years.
News
FDA grants accelerated approval for new treatment of female cancers
Eligible patients for mirvetuximab soravtansine include those with folate receptor alpha, chemo resistant ovarian, fallopian and peritoneal...
From the Journals
Analysis affirms that giving birth protects against endometrial cancer
Researchers found that more live births has a protective effect on the risk of endometrial cancer, even when accounting for other risk factors.
Conference Coverage
How AI is, or will soon be, relevant in radiation oncology
Radiation oncologists at ASTRO 2022 discuss practical applications of AI, and new research findings.
From the Journals
Chronic stress, especially race related, may hasten cancer death
High allostatic load was associated with an 80% increased risk of cancer death among all study participants.
From the Journals
Third COVID booster benefits cancer patients
For the first time, researchers have quantified the benefits of boosters for COVID-19 in cancer patients.
Latest News
HPV vaccine effectiveness dependent on age at receipt
HPV vaccination does not have any therapeutic effect on HPV infections already acquired, which is likely to explain the difference in infection...
Latest News
Study uncovers two molecular subgroups of cervical cancer
Patients with so-called C2 tumors were more than twice as likely to die from their cervical cancer at any point during the follow-up period - up...
Feature
Hair straighteners’ risk too small for docs to advise against their use
Primary care doctors are unlikely to address the increased risk of uterine cancer in women who frequently use hair straighteners that a new study...
Opinion
Germline genetic testing: Why it matters and where we are failing
Cancer and medical societies recommend universal genetic counseling and testing for patients diagnosed with epithelial ovarian cancer.
From the Journals
Hair-straightening products linked with uterine cancer risk: Study
The products have previously been associated with higher risks of breast and ovarian cancer.